Cambrex Advances US and European Expansions
Story summaryEAST RUTHERFORD, N.J., March 23, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced the completion of initial engineering studies for its new, large-scale active pharmaceutical ingredient (API) manufacturing plant in Charles City, Iowa. This mil…
Read at The Korea HeraldOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.